Teva Pharmaceutical Industries has upsized its planned US$2.06bn offering of sustainability linked notes (SLN) and priced approximately US$2.49bn (equivalent) of senior notes as part of a debt tender offer. The…
Teva Pharmaceutical Industries has upsized its planned US$2.06bn offering of sustainability linked notes (SLN) and priced approximately US$2.49bn (equivalent) of senior notes as part of a debt tender offer. The…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference